Yahoo India Web Search

Search results

1. www.bloomberg.com › quote › EOLS:USEOLS: Evolus Inc Stock Price Quote - NASDAQ GM - Bloomberg

   www.bloomberg.com › quote › EOLS:US

   • Cached

   4 days ago · Stock analysis for Evolus Inc (EOLS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   • Employees: 273

2. www.marketbeat.com › instant-alerts › nasdaq-eolsBNP Paribas Financial Markets Increases Stock Holdings in ...

   www.marketbeat.com › instant-alerts › nasdaq-eols

   • Cached

   4 days ago · Evolus, Inc, a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

3. simplywall.st › nasdaq-eols › evolusEvolus NasdaqGM:EOLS Stock Report - Simply Wall St

   simplywall.st › nasdaq-eols › evolus

   • Cached

   5 days ago · www.evolus.com. Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar ...

4. People also ask

   Is Evolus a good stock to buy?

   • Evolus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $20.60, Evolus has a forecasted upside of 50.4% from its current price of $13.70.

   Evolus (EOLS) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/EOLS/

   See all results for this question

   Who makes Evolus products?

   • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

   Evolus (EOLS) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/EOLS/

   See all results for this question

   Is Evolus a cash-pay beauty company?

   • Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

   Evolus (Nasdaq:EOLS) - Stock Price, News & Analysis - Simply Wall St

   simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-eols/evolus

   See all results for this question

   Does Evolus serve pharmaceutical industry?

   • Evolus serves pharmaceutical industry in the United States. Stock analysis for Evolus Inc (EOLS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

   EOLS: Evolus Inc Stock Price Quote - NASDAQ GM - Bloomberg

   www.bloomberg.com/quote/EOLS:US

   See all results for this question

5. www.realself.com › reviews › jeuveauJeuveau Reviews | Was it Worth It? | RealSelf

   www.realself.com › reviews › jeuveau

   • Cached

   4 days ago · RealSelf features 54 Jeuveau reviews you can trust, from real people like you. More about Jeuveau. 91%. WORTH IT. Based on 34 recent ratings. Last updated: July 12, 2024. 31. Worth It. 2.

   • 91% (65)

6. markets.ft.com › data › equitiesEvolus Inc, EOLS:NMQ summary - FT.com - Financial Times

   markets.ft.com › data › equities

   • Cached

   4 days ago · On Friday, Evolus Inc (EOLS:NMQ) closed at 11.77, -23.73% below its 52-week high of 15.43, set on Mar 04, 2024. Data delayed at least 15 minutes, as of Jul 12 2024 21:00 BST. All markets data located on FT.com is subject to the FT Terms & Conditions. All content on FT.com is for your general information and use only and is not intended to ...

   • Bid: 11.43
   • Low: 11.30

   • High: 11.64
   • Open: 11.64

7. www.marketbeat.com › stocks › NASDAQEvolus (EOLS) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   4 days ago · Evolus, Inc., a performance beauty company, focuses on delivering products in the cash-pay aesthetic market in the United States, Canada, and Europe. The company offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

8. www.marketbeat.com › stocks › NASDAQEvolus (EOLS) Stock Forecast and Price Target 2024 - MarketBeat

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   4 days ago · What is Evolus' forecast for 2024? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Evolus is $21.67, with a high forecast of $27.00 and a low forecast of $16.00.